Phenolic compounds from Diarthron lessertii: isolation, cytotoxicity, and interaction with cancer signaling pathway, FOXO3a

Hussein Biganeh, Morteza Sadeghi, Mehran Miroliaei, Mahnaz Khanavi, Mustafa Ghanadian · 2026

Read Phenolic compounds from Diarthron lessertii: isolation, cytotoxicity, and interaction with cancer signaling pathway, FOXO3a by Hussein Biganeh, Morteza Sadeghi, Mehran Miroliaei, Mahnaz Khanavi, Mustafa Ghanadian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13441029.txt.

Description

Hussein Biganeh and colleagues isolate phenolic compounds from the plant Diarthron lessertii and test them against cervical cancer cells, reporting in 2026. Plant phenolics are a rich hunting ground for cancer drug leads. Chromatography pulled nine compounds from shoot extract, spanning lignans, a biflavonoid, a bicoumarin, and five flavonoids, each identified by magnetic resonance and mass readings. A standard viability assay graded their killing of HeLa cells.

One lignan, epinortrachelogenin, hit hardest, halving cell growth at a moderate dose. Reporter tests showed the same compound selectively switching on FOXO3a, a forkhead protein that can order cancer cells to die or stall. Computer docking placed the lignan snugly in the protein's binding pocket, matching the laboratory signal. The authors nominate the compound as a lead for FOXO3a-targeted drug design, pending wider testing.

Catalog record

CREATORHussein Biganeh, Morteza Sadeghi, Mehran Miroliaei, Mahnaz Khanavi, Mustafa Ghanadian
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13441029

Browse the full library · About the Tower of Babel